期刊文献+

RNA干扰技术的基础研究与应用 被引量:4

The Basic Research and Application of RNA Interfering
下载PDF
导出
摘要 RNA干扰技术(RNAi)是一项高效率、强特异性的基因沉默技术。自1998年发现RNA干扰现象以来,RNAi吸引很多国内外科学家的研究兴趣。经过10多年的潜心研究,现在对该技术的参与成分、作用机理都有了较深入地了解。同时,随着生物学知识的完善和生物技术与基因工程的发展,研究人员对RNAi在基因功能研究、疾病(如肿瘤)相关的基因治疗、新药的研究与开发等方面的应用进行了广泛的探索,并且已经显示该技术的潜在应用价值,但是RNAi的自身缺陷制约了其在临床治疗等方面的实际应用。综述前人的研究结果,系统阐述了RNAi的发生、作用机理、缺陷以及其应用,为相关科学研究提供参考。 RNA interfering(RNAi)is a high efficient and specific gene silencing technology,that has attracted growing research since its occurrence in 1998.Now the components as well as the mechanism of RNAi have been well elucidated after more than ten years'research.With the perfection of biology knowledge and the development of biotechnique as well as genetic engineering,researchers have explored extensively about the application of RNAi on gene function research,disease-related gene therapy,the research and development of new drugs.RNAi has shown its potential value.However,the defects of RNAi have restricted its actual application in the clinical treatment.In this paper,we elucidated the onset,mechanism,defects as well as application of RNAi systematically based on previous studies with the aim to provide reference for research.
作者 郭会灿
出处 《生物技术通报》 CAS CSCD 北大核心 2011年第4期66-69,共4页 Biotechnology Bulletin
关键词 RNAI SIRNA miRNA DSRNA DICER RISC RNAi siRNA miRNA dsRNA Dicer RISC
  • 相关文献

参考文献4

二级参考文献60

  • 1付洁,宋海峰,钱小红.siRNA作为基因治疗药物的研究难题[J].中国新药杂志,2007,16(7):506-510. 被引量:1
  • 2Prezas P,Arlt M J,Viktorov P,et al.Overexpression of the human tissue kallikrein genes KLK4,5,6,and 7 increases the malignant phenotype of ovarian cancer cells[J].Biological Chemistry,2006,387(6):807-811.
  • 3Werle E.Zur Kenntnis des haushalts des Kallikreins[J].Biochem,1934,Z 269:415-434.
  • 4Christina V,Obiezu,Eleftherios P,Diamandis.Human tissue kallikrein gene family:applications in cancer[J].Cancer Letters,2005,224:1-24.
  • 5Steuber T,Vickers AJ,Serio AM,et al.Comparison of Free and Total Forms of Serum Human Kallikrein 2 and Prostate-Specific Antigen for Prediction of Locally Advanced and Recurrent Prostate Cancer[J].Clin Chem,2007,53(2):233-240.
  • 6Planque C,de Monte M,Guyetant S,et al.KLK5 and KLK7,two members of the human tissue kallikrein family,are differentially expressed in lung cancer[J].Biochem Biophys Res Commun,2005,329(4):1260-1266.
  • 7Ishida-Yamamoto A,Deraison C,Bonnart C,et al.LEKTI is localized in lamellar granules,separated from KLK5 and KLK7,and is secreted in the extracellular spaces of the superficial stratum granulosum[J].J Invest Dermatol,2005,124(2):360-366.
  • 8Sher YP,Chou CC,Chou RH,et al.Human kallikrein 8 protease confers a favorable clinical outcome in non-small cell lung cancer by suppressing tumor cell invasiveness[J].Cancer Res,2006,66(24):11763-11770.
  • 9White NM,Mathews M,Yousef GM,et al.Human kallikrein related peptidases 6 and 13 in combination with CA125 is a more sensitive test for ovarian cancer than CA125 alone[J].Cancer Biomarkers,2009,5(6):279-287.
  • 10White NM,Mathews M,Yousef GM,et al.KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma[J].British Journal of Cancer,2009,101(7):1107-1113.

共引文献8

同被引文献48

  • 1陈克平,唐旭东.RNAi技术研究进展[J].江苏大学学报(自然科学版),2004,25(4):336-340. 被引量:4
  • 2卢翠玲,杨巍,胡召元,刘以训.颗粒细胞的增殖分化及其在卵泡发育中的作用[J].科学通报,2005,50(21):2341-2347. 被引量:44
  • 3郑正荣,杨春康,戴起宝.趋化因子受体对肿瘤生物学行为的影响[J].世界华人消化杂志,2006,14(5):513-518. 被引量:7
  • 4陈宏远,谭毅,蔡绍晖,马伟峰,郭芝刚,杜军,蔡绍皙.基质细胞衍生因子-1及其受体CXCR4在肿瘤转移中的作用[J].生物医学工程学杂志,2007,24(5):1180-1183. 被引量:7
  • 5Kang HJ, Jung SK, Kim SJ, et ol. Structure of human alpha- enolase (hENO1), a muhifunctional glycolytic enzyme [J]. Acta Crystallogr D Biol Crystallogr, 2008, 64 (Pt 6): 651-657.
  • 6Sutton-McDowall ML, Gilchrist RB, Thompson JG. The pivotal role of glucose metabolism in determining oocyte developmental competence [J]. Reproduction, 2010, 139 (4): 685-695.
  • 7Gilbert AB, Evans AJ, Perry MM, et al. A method for separating the granulosa cells, the basal lamina and the theca of the preovulatory ovarian follicle of the domestic fowl (Gallus domesticus)[J]. J Reprod Fertil, 1977, 50 (1): 179-181.
  • 8Zhao J, Chang AC, Li C, et al. Comparative proteomics analysis of barrett metaplasia and esophageal adeno-carcinoma using two-dimensional liquid mass mapping [J]. Mol Cell Proteomics, 2007, 6 (6): 987-999.
  • 9Tomaino B, Cappello P, Capello M, et al. Circulating autoantibodies to phosphorylated ct-enolase are a hall-mark of pancreatic cancer [J]. J Proteome Res, 2011, 10 (1): 105- 112.
  • 10Ornellas AA. Editorial Comment to Potential tumor markers of renal cell carcinoma: α-Enolase for posto-perative follow up, and galectin-1 and galectin-3 for primary detection [J]. Int J Urol, 2013, 20 (5): 535-536.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部